Effects of steroid and bevacizumab in retinal vascular diseases

Effects of steroid and bevacizumab in retinal vascular diseases - Effects of steroid and bevacizumab

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000000921

Enrollment

200

Registered

2007-12-03

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinal vascular diseases (diabetic retinopathy, retinal vein occulusion, age-related maculopathy)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: subjects with retinal vascular diseases

Exclusion criteria

Exclusion criteria: subjects with systemic risk factors of macrovascular diseases) subjects with risk factors for ophthalmological surgeries

Design outcomes

Primary

Measure	Time frame
examination of fundus findings by ophthalmoloscope, visual acuity, retinal thickness, other general ophthalolmological examinations	—

Secondary

Measure	Time frame
Ophthalmological complications including ocular hypertension, ocular circulation diseases), and systemic complications (hypertension)	—

Countries

Japan

Contacts

Public ContactSakiko Goto

Yamagata University Hospital Ophthalmology

nakano-ygt@umin.ac.jp023-628-5374

Outcome results